Gerresheimer saw the highest growth of 499% in patent filings in November and 879% in grants in December in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 19% and grants by 74%. GlobalData’s DataBook provides a comprehensive analysis of Gerresheimer‘s patent filings and grants. Buy the databook here.
Gerresheimer has been focused on protecting inventions in Canada(CA) with 38 publications in Q4 2023
The Canada(CA) Patent Office dominates the patent filings and grants with nearly . The China(CN), United States(US), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where Gerresheimer is filings its patents. Among the top granted patent authorities, Gerresheimer has 73% of its grants in Canada(CA), 12% in United States(US) and 10% in European Patent Office(EPO).
Patents related to climate change lead Gerresheimer's portfolio
Gerresheimer has the highest number of patents in climate change. For climate change no patents were filed and 100% of patents were granted in Q4 2023.
Drug delivery devices related patents lead Gerresheimer portfolio followed by packaging, and manufacturing/industrial
Gerresheimer has highest number of patents in drug delivery devices followed by packaging, manufacturing/industrial, pharmaceutical & healthcare packaging. For drug delivery devices, nearly 100% of patents were filed and 44% of patents were granted in Q4 2023.
For comprehensive analysis of Gerresheimer's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.